Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNewmark Security Regulatory News (NWT)

Share Price Information for Newmark Security (NWT)

Share Price is delayed by 15 minutes
Get Live Data
115.00    0.00 (0.00%)
Bid:
110.00
Ask:
120.00
Spread: 10.00 (9.091%)
Market Cap: £10.84m
NWT Live PriceLast checked at - London Stock Exchange

Intraday Newmark Security Share Chart

Year-end trading update

9 Jun 2021 07:00

RNS Number : 2283B
Newmark Security PLC
09 June 2021
 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (amendment) (EU Exit) Regulations 2019/310.

 

Newmark Security plc

("Newmark", the "Company" or the "Group")

 

Year-end trading update

 

Newmark Security plc (AIM: NWT), a leading provider of products and services in the security and data sectors announces an update on trading for the year ended 30 April 2021 ("FY 20/21").

 

Trading for the second half of FY 20/21 continued broadly in line with management's expectations, with the Company showing an improved performance in H2 as compared to H1. As a result, subject to audit, the Company expects to report revenue for FY 20/21 of c. £17.7m, 6% lower than FY 19/20 (£18.8m), and a marginal profit for the full year. This reduction in full year revenue is significantly lower than what was achieved at the half year (23% reduction in revenue compared to H1 19/20), demonstrating the improved trading in H2.

 

During the year, Grosvenor Technology ("Grosvenor"), which specialises in data security and privacy, achieved further growth in its Human Capital Management ("HCM") activities. Increases in sales from existing and new HCM customers outstripped the expected reduction from the merger of Ultimate Software with Kronos Incorporated as anticipated, resulting in year-on-year growth of 6%. Grosvenor's Access Control division was impacted to a greater degree by COVID-19 with less ability for our installer network to attend sites during lockdown, although the second half of the year showed improvement over the first half as expected and with Janus C4 continuing to build traction.

 

Safetell, the Group's asset protection division, managed to recover revenues well in the second half of the year resulting in a full year c. 7% reduction against last year compared to a 24% reduction reported at the half year, whilst still maintaining a strong sales pipeline.

 

Outlook

 

With the expectation that the COVID-19 pandemic will continue to become more controlled with the successful roll out of vaccinations, the Directors of Newmark are optimistic about future trading. HCM is expected to continue growing from the continued onboarding of Software Houses and the further roll out of its Software-as-a-Service ("SaaS") and Clock-as-a-Service ("ClaaS") subscription services. Further focus is being placed on the transition from Legacy Access Control sales to Janus C4 and in Safetell we anticipate steady growth from a more considered and targeted approach to the market.

 

The Board appreciates the amount of hard work from the Newmark team that has gone into delivering a set of good results considering the events of the past year.

 

Newmark Security plc

Marie-Claire Dwek, Chief Executive Officer

Graham Feltham, Group Finance Director

 

Tel: +44 (0) 20 7355 0070

www.newmarksecurity.com

Allenby Capital Limited

(Nominated Adviser and Broker)

Tel: +44 (0) 20 3328 5656

James Reeve / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales & Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSDFMAEFSEEM
Date   Source Headline
2nd Jun 202612:47 pmRNS-RInvestor Event – Mello London
21st May 20269:00 amRNSFull Year Trading Update
25th Mar 202611:43 amRNSHolding(s) in Company
27th Feb 20265:00 pmRNSTotal Voting Rights
13th Feb 20267:00 amRNSExercise of options and total voting rights
10th Feb 20267:00 amRNSDirectorate change
15th Jan 202612:00 pmRNS-RInvestor Event - Mello
15th Jan 20267:00 amRNSHalf-year Financial Report
9th Jan 20267:00 amRNSNotice of Interim Results
5th Jan 20263:00 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSDirectorate change
12th Nov 20257:00 amRNS-RInvestor Event - Mello London
31st Oct 20255:00 pmRNSTotal Voting Rights
24th Oct 20257:00 amRNSExercise of options and total voting rights
23rd Oct 20252:00 pmRNSResult of AGM
23rd Oct 20257:00 amRNSAGM Statement
15th Oct 20257:00 amRNSUpdate re. Response to Shareholder Letter
8th Oct 20252:01 pmRNSTrading Update and Response to Shareholder Letter
30th Sep 20255:00 pmRNSTotal Voting Rights
19th Sep 20253:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20253:10 pmRNSExercise of options and TVR
4th Sep 20257:00 amRNSFinal Results
11th Aug 20257:00 amRNSNotice of Results and Investor Presentation
7th Aug 20257:00 amRNSFive-Year Supply Agreement with Protime NV
30th May 20259:34 amRNS-RInvestor Event - Mello 2025
20th May 20257:00 amRNSFull Year Trading Update
30th Apr 20257:00 amRNS-RNorth America Partnership Agreement with Synerion
19th Mar 20259:01 amRNSHolding(s) in Company
18th Mar 20257:00 amRNSTrading Update
17th Mar 20257:00 amRNSHolding(s) in Company
14th Mar 20257:35 amRNSHolding(s) in Company
14th Mar 20257:32 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSHolding(s) in Company
5th Mar 20254:11 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSHalf-year Report
23rd Jan 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSNotice of Interim Results
22nd Oct 20242:01 pmRNSResult of AGM
22nd Oct 20247:00 amRNSAGM Statement
20th Sep 202412:22 pmRNSPosting of Annual Report and Notice of AGM
11th Sep 202410:13 amRNSGrant of options and adoption of LTCIP
10th Sep 20242:10 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSFinal Results
2nd Sep 20247:00 amRNSNotice of results and investor presentation
14th May 20247:00 amRNSFull year trading update
20th Feb 20244:11 pmRNSDirector dealing
25th Jan 20247:00 amRNSHalf-year Report
21st Dec 20237:00 amRNSNotice of Interim Results
30th Nov 20232:59 pmRNSHolding(s) in Company
28th Nov 20232:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.